Chronic graft-versus-host-disease treatment in Brazil: analyses of failure-free survival.
暂无分享,去创建一个
L. Daudt | A. Seber | E. Miranda | A. Vigorito | C. Bonfim | F. Duarte | Morgani Rodrigues | G. Fatobene | M. Macedo | Marcos Paulo Colella | V. Funke | M. Moreira | V. Colturato | Lívia Mariano | M. Flowers | P. Martin | L. B. Ribeiro | M. Colella | M. D. Flowers
[1] M. Flowers,et al. Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia , 2021, Bone Marrow Transplantation.
[2] L. Bouzas,et al. DIAGNOSIS AND TREATMENT OF GVHD , 2021, JBMTCT.
[3] L. Bouzas,et al. Hematopoietic cell transplantation in pediatric patients with acute leukemias or myelodysplastic syndrome using unrelated adult or umbilical cord blood donors in Brazil , 2020, Pediatric transplantation.
[4] J. Garcia,et al. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] E. Holler,et al. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] Stephanie J. Lee,et al. Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] P. Campregher,et al. Survival and graft‐versus‐host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA‐matched related donor: retrospective analysis of 334 consecutive patients , 2015, European journal of haematology.
[8] H. Greinix,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .
[9] J. Pidala,et al. Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease , 2015, Haematologica.
[10] Daniel Wolff,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[11] W. Wood,et al. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[12] B. Sandmaier,et al. Failure-free survival after initial systemic treatment of chronic graft-versus-host disease. , 2014, Blood.
[13] S. Svegliati,et al. Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD. , 2013, Blood.
[14] J. Shelhamer,et al. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] B. Sandmaier,et al. Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease. , 2013, Blood.
[16] B. Kurland,et al. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[17] B. Storer,et al. Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] B. Storer,et al. Clinical benefit of response in chronic graft-versus-host disease. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] J. Miguel,et al. Evaluation of prognostic factors among patients with chronic graft-versus-host disease , 2012, Haematologica.
[20] J. Klein,et al. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. , 2011, Blood.
[21] L. Bouzas,et al. Brazilian workshop model to train investigators in chronic graft-versus-host disease clinical trials according to the 2005-2006 National Institutes of Health recommendations , 2011, Revista brasileira de hematologia e hemoterapia.
[22] B. Storer,et al. Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[23] L. Bouzas,et al. A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria: efforts to establish a Brazil-Seattle consortium as a platform for future collaboration in clinical trials , 2011, Revista brasileira de hematologia e hemoterapia.
[24] B. Storer,et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. , 2009, Blood.
[25] J. Fay,et al. Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. , 2009, Blood.
[26] Steven Hirschfeld,et al. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report , 2006 .
[27] R. Storb,et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. , 2004, Blood.
[28] M. Flowers,et al. Chronic graft-versus-host disease. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[29] R. Storb,et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. , 2002, Blood.
[30] J. V. Stone,et al. Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation , 1999 .
[31] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.